We recently published a list of 10 Stocks Lead Monday’s Charge Amid Market Bloodbath. In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against other stocks that lead Monday’s charge amid market bloodbath.
The stock market kicked off the trading week in a bloodbath, erasing last week’s gains, with all major indices posting heavy losses following President Donald Trump’s confirmation that tariffs on goods from Mexico and Canada are set to take effect on Tuesday.
The tech-heavy Nasdaq posted the biggest loss, down 2.64 percent, followed by S&P at 1.76 percent, and Dow Jones at 1.48 percent.
According to Trump, there was no room left for Mexico and Canada, and his 25-percent tariff for the two countries “will start.” He also signed an additional 10-percent tariff on goods from China.
Despite the market decline, ten companies bucked an overall pessimistic sentiment, making it to the top gainers list mainly due to bullish ratings and earnings performance, among others. In this article, we have detailed the reasons behind their gains.
To come up with Monday’s top gainers, we considered only the stocks with $2 billion in market capitalization and $5 million in daily trading volume.
A pharmacist and a customer discussing a novel therapeutic oral health product in a pharmacy.
Haleon plc (NYSE:HLN)
British multinational healthcare firm Haleon plc (NYSE:HLN) rose for a second day on Monday, adding 3.93 percent to close at $10.58 apiece as investors cheered its bullish outlook from an investment firm.
Barclays in a research report on Monday said it maintained a “buy” rating on HLN and set a price target of £4.45.
The upgrade followed a separate coverage from Kepler Capital last week, which also gave HLN a “buy” rating and a price target of £4.25.
Last week, Haleon plc (NYSE:HLN) said it achieved a 37-percent increase in its net income attributable to shareholders for full year 2024, ending at £1.44 billion versus £1.05 billion in 2023.
Revenues, however, were lower at £11.2 billion versus £11.3 billion year-on-year.
Overall, HLN ranks 7th on our list of stocks that lead Monday’s charge amid market bloodbath. While we acknowledge the potential of HLN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than HLN but trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap
Disclosure: None. This article is originally published at Insider Monkey.